US EditionPublished • loading... • Updated
ADC Therapeutics (NYSE:ADCT) Major Shareholder Sells $735,858.75 in Stock
Summary by watchlistnews.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
ADC Therapeutics (NYSE:ADCT) Major Shareholder Sells $735,858.75 in Stock
ADC Therapeutics SA (NYSE:ADCT – Get Free Report) major shareholder Redmile Group, Llc sold 196,229 shares of the stock in a transaction on Tuesday, March 31st. The stock was sold at an average price of $3.75, for a total value of $735,858.75. Following the sale, the insider directly owned 15,470,502 shares of the company’s stock, […]
Insider Selling: ADC Therapeutics (NYSE:ADCT) Major Shareholder Sells 196,229 Shares of Stock
ADC Therapeutics SA (NYSE:ADCT – Get Free Report) major shareholder Redmile Group, Llc sold 196,229 shares of ADC Therapeutics stock in a transaction on Tuesday, March 31st. The stock was sold at an average price of $3.75, for a total transaction of $735,858.75. Following the completion of the transaction, the insider directly owned 15,470,502 shares […]
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
